Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >ALK-IN-26
ALK-IN-26
  • ALK-IN-26

ALK-IN-26 NEW

Price $35 $79 $123
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-11-10

Product Details

Product Name: ALK-IN-26 CAS No.: 2447607-85-2
Purity: 99.91% Supply Ability: 10g
Release date: 2025/11/10

Product Introduction

Bioactivity

NameALK-IN-26
DescriptionALK-IN-26 is an ALK inhibitor with potential anticancer activity, demonstrating antiproliferative effects against glioblastoma and inducing apoptosis, autophagy, and necrosis.
In vitroIn GL261 cells, ALK-IN-26 (0.5 μM, 1.0 μM, 2.0 μM; 24 hours, 48 hours, 72 hours) induced apoptosis of glioblastoma in a concentration- and time-dependent manner, and resulted in cells (24.5%) entering the S phase when treated with 1 μM for 72 hours, but barely proceeding to the G2/M phase[1].
In vivoIn male C57BL/6J mice, ALK-IN-26 (5 mg/kg; i.v.; single dose) could be rapidly absorbed (Tmax = 0.58 hours) with an acceptable half-life (T1/2 = 3.55 hours) and bioavailability (F = 38.4%)[1].
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
KeywordsALKIN26 | ALK
Inhibitors Related10-Hydroxydecanoic Acid | Ascorbyl palmitate | Hydralazine hydrochloride | Berberine hydrogen sulphate | 3-Aminobenzamide | Cystamine dihydrochloride | (Iso)-Z-VAD(OMe)-FMK | Tauroursodeoxycholate | Olaparib | Dihydromyricetin | Berberine sulfate | Cinchonine
Related Compound LibrariesAnti-Lung Cancer Compound Library | Apoptosis Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Tyrosine Kinase Inhibitor Library | Kinase Inhibitor Library | Angiogenesis related Compound Library | Inhibitor Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$2140.00/25mg
VIP2Y
TargetMol Chemicals Inc.
2025-10-27
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2024-06-28
$1980.00/50mg
VIP4Y
TargetMol Chemicals Inc.
2024-10-23

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY